Lapatinib Resistance in Patients With Breast Cancer
Status: WITHDRAWN
Study type: OBSERVATIONAL
Conditions: Breast Cancer
Interventions: DRUG: lapatinib ditosylate|GENETIC: fluorescence in situ hybridization|GENETIC: gene expression analysis|GENETIC: mutation analysis|GENETIC: polymerase chain reaction|GENETIC: reverse transcriptase-polymerase chain reaction|OTHER: cell sorting|OTHER: immunohistochemistry staining method|OTHER: laboratory biomarker analysis
Sponsor: Case Comprehensive Cancer Center
Collaborators: National Cancer Institute (NCI)